Jason Haddock, CFO at ARRAY BIOPHARMA INC (ARRY), sold 25,000 shares at $14.87 ($372K) on 2018-07-30, disclosed to the SEC on 2018-07-31.
Open-market sale of $372k ARRY by CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| ARRY | SELL | 2018-01-16 | $103K | — | Filing → |